ESMO Immuno-Oncology Virtual Congress 2020 | #ESMOImmuno20 Virtual Congress: Prof. Kevin Harrington, Scientific Co-Chair, tells you why this event is so unique. Remember that ESMO Members register... | By ESMO - European
![Kevin HARRINGTON | Institute of Cancer Research, London | Division of Radiotherapy and Imaging | Research profile Kevin HARRINGTON | Institute of Cancer Research, London | Division of Radiotherapy and Imaging | Research profile](https://i1.rgstatic.net/ii/profile.image/556535446872065-1509699798223_Q512/Kevin-Harrington-2.jpg)
Kevin HARRINGTON | Institute of Cancer Research, London | Division of Radiotherapy and Imaging | Research profile
![Immunotherapy for recurrent or metastatic HNSCC: What are the practical considerations? - touchONCOLOGY Immunotherapy for recurrent or metastatic HNSCC: What are the practical considerations? - touchONCOLOGY](https://embed-ssl.wistia.com/deliveries/a43b9d4a477e79a284fe2ef2d33f001b.jpg?image_crop_resized=640x360)
Immunotherapy for recurrent or metastatic HNSCC: What are the practical considerations? - touchONCOLOGY
![Kevin Harrington, The Original Shark from Shark Tank and Inventor of The Infomercial Joins the Advisory Board of USARAD including its SecondOpinions.com® Division Kevin Harrington, The Original Shark from Shark Tank and Inventor of The Infomercial Joins the Advisory Board of USARAD including its SecondOpinions.com® Division](http://ww1.prweb.com/prfiles/2021/01/11/17654673/Kevin%20Harrington%200159%20AAA%202.jpeg)